AVGR - Bathi resik saben saham (EPS TTM) Avinger, Inc

Recurring payments for disposable vascular surgery instruments create a steady cash flow for Avinger, Inc. (AVGR). The current trailing twelve-month net income per share illustrates capital management efficiency, where -12.44 determines the latest valuation metric. Growth is driven by the implementation of light-guide systems for arterial therapy and organic distribution expansion without utilizing external financing through mergers.

Geopolitical restrictions on technology exports to Asia directly impact the annual net income per share trend for Avinger, Inc. (AVGR). This indicator reflects the actual profitability of the business, stripped of management manipulations. The calculation is based on consolidated net profit over 12 months divided by the number of shares. This price action signals the company's ability to overcome the microchip shortage. This is a key tool for capital rebalancing within the high-tech sector.